Connecticut’s state Department of Consumer Protection announced a new condition that will allow patients to be prescribed medical marijuana. The condition is degenerative spinal disorders.
Marijuana was approved Thursday by the General Assembly’s regulations review committee to treat the chronic pain that accompanies spinal degeneration.
Some of the symptoms of degenerative spinal disorders including burning, tingling and a stabbing feeling throughout the body.
Connecticut now serves 29,543 patients and has a total of 31 conditions approved for adults, and eight for patients under 18.
The state has also reclassified the first FDA approved marijuana-based drug Epidiolex, as a Schedule V drug, the least restrictive schedule in the Controlled Substances Act.
“It’s always been important to us at DCP to make sure that patients get access to the medication they need as quickly as possible,” Consumer Protection Commissioner Michelle Seagull said. “These updates to the regulations mean that more patients with severe debilitating conditions will have additional options for medical treatment.”
